Literature DB >> 526754

The effect of metoclopramide and haloperidol on tardive dyskinesia [proceedings].

D N Bateman, D K Dutta, H A McClelland, M D Rawlins.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 526754      PMCID: PMC2043655     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  7 in total

1.  Cardiovascular dopamine receptor stimulation antagonized by metoclopramide.

Authors:  M D Day; P R Blower
Journal:  J Pharm Pharmacol       Date:  1975-04       Impact factor: 3.765

2.  [Clinical and electroencephalographic effects of methoclopramide in psychiatry].

Authors:  P Borenstein; G Bles
Journal:  Therapie       Date:  1965 Jul-Aug       Impact factor: 2.070

3.  Extrapyramidal side-effects of metoclopramide.

Authors:  M Kataria; M Traub; C D Marsden
Journal:  Lancet       Date:  1978-12-09       Impact factor: 79.321

4.  Tardive dyskinesia associated with metoclopramide.

Authors:  S Lavy; E Melamed; S Penchas
Journal:  Br Med J       Date:  1978-01-14

5.  Inhibition by apomorphine of the metoclopramide-induced catalepsy and increase in striatal homovanillic acid content.

Authors:  L Ahtee
Journal:  Br J Pharmacol       Date:  1975-11       Impact factor: 8.739

Review 6.  The neuropharmacology of abnormal involuntary movement disorders (the dyskinesias).

Authors:  C D Marsden
Journal:  Mod Trends Neurol       Date:  1975

7.  Idiopathic Parkinsonism treated with an extracerebral decarboxylase inhibitor in combination with levodopa.

Authors:  D B Calne; J L Reid; S D Vakil; S Rao; A Petrie; C A Pallis; J Gawler; P K Thomas; A Hilson
Journal:  Br Med J       Date:  1971-09-25
  7 in total
  3 in total

Review 1.  Antipsychotic medication for elderly people with schizophrenia.

Authors:  R G Marriott; W Neil; S Waddingham
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

Review 2.  Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia.

Authors:  Hanna Bergman; John Rathbone; Vivek Agarwal; Karla Soares-Weiser
Journal:  Cochrane Database Syst Rev       Date:  2018-02-06

Review 3.  Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia.

Authors:  Hany G El-Sayeh; John Rathbone; Karla Soares-Weiser; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.